Loading clinical trials...
Loading clinical trials...
An Open-label, Randomized, Phase III, Multicenter Clinical Trial Comparing the Efficacy and Safety of Individualized Intraperitoneal and System Chemotherapy Versus System Chemotherapy as First-line Chemotherapy for Advanced Gastric Cancer
Conditions
Interventions
Docetaxel
Oxaliplatin
+4 more
Locations
8
China
Ma'anshan People's Hospital
Ma’anshan, Anhui, China
Jiangyin People's Hospital
Jiangyin, Jiangsu, China
Nanjing Gaochun People's Hospital
Nanjing, Jiangsu, China
Nanjing Lishui People's Hospital
Nanjing, Jiangsu, China
The Comprehensive Cancer Center of Nanjing Drum Tower Hospital
Nanjing, Jiangsu, China
Suqian People's Hospital
Suqian, Jiangsu, China
Start Date
April 1, 2013
Primary Completion Date
December 1, 2018
Completion Date
December 1, 2019
Last Updated
September 15, 2017
NCT06885697
NCT06313203
NCT06510010
NCT04724499
NCT07267806
NCT06630130
Lead Sponsor
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions